PAP-1 ameliorates DSS-induced colitis with involvement of NLRP3 inflammasome pathway
Authors:
- 24 July 2019
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 75, 105776
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81470809, 81500403)
This publication has 48 references indexed in Scilit:
- Activation and regulation of the inflammasomesNature Reviews Immunology, 2013
- IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cellsJournal of Experimental Medicine, 2012
- Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophilsNature Immunology, 2011
- Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasomeGut, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequencesJournal of General Physiology, 2010
- Voltage-gated potassium channels as therapeutic targetsNature Reviews Drug Discovery, 2009
- The K+ channels KCa3.1 and Kv1.3 as novel targets for asthma therapyBritish Journal of Pharmacology, 2009
- Targeting Effector Memory T Cells with the Small Molecule Kv1.3 Blocker PAP-1 Suppresses Allergic Contact DermatitisJournal of Investigative Dermatology, 2007
- Interleukin-1β targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitisBiochemical and Biophysical Research Communications, 2005